Suppr超能文献

两名复发性播散性朗格汉斯细胞组织细胞增生症女孩在接受治疗后发生急性非淋巴细胞白血病。

Occurrence of acute nonlymphoblastic leukemia in two girls after treatment of recurrent, disseminated Langerhans cell histiocytosis.

作者信息

Kager L, Heise A, Minkov M, Möbius D, Kotte W, Schulte-Overberg U, Henze G, Gadner H

机构信息

St. Anna Children's Hospital, Vienna, Austria.

出版信息

Pediatr Hematol Oncol. 1999 May-Jun;16(3):251-6. doi: 10.1080/088800199277317.

Abstract

The occurrence of Langerhans cell histiocytosis (LCH) and acute leukemia in one individual has rarely been observed. Despite few exceptions, two distinct patterns of association appear evident: acute lymphoblastic leukemia preceding LCH and LCH preceding acute nonlymphoblastic leukemia (ANLL). The latency of ANLL after the diagnosis of LCH is suggestive of a therapy-related process. This report describes two new cases in whom ANLL was diagnosed 7 years 8 months and 5 years 8 months after the start of initial treatment of disseminated recurrent LCH. Morphology showed blasts from FAB-type M4/M5 in the first patient, who died due to progression of leukemia. The second patient showed myelodysplastic syndrome (refractory anemia with excess of blasts in transformation; RAEB-t) and is now in remission from leukemia 3 years 11 months after allogeneic bone marrow transplantation. The review of a total of 26 patients with ANLL after LCH suggests that the disease has a poor prognosis and allogeneic BMT seems to be the treatment of choice.

摘要

朗格汉斯细胞组织细胞增多症(LCH)与急性白血病在同一患者身上同时出现的情况鲜有报道。尽管有少数例外,但两种不同的关联模式似乎很明显:急性淋巴细胞白血病先于LCH出现,以及LCH先于急性非淋巴细胞白血病(ANLL)出现。LCH诊断后ANLL的潜伏期提示这是一个与治疗相关的过程。本报告描述了两例新病例,在播散性复发性LCH初始治疗开始后7年8个月和5年8个月诊断出ANLL。第一例患者的形态学显示为FAB分型的M4/M5原始细胞,该患者因白血病进展而死亡。第二例患者表现为骨髓增生异常综合征(转化型难治性贫血伴原始细胞增多;RAEB-t),在异基因骨髓移植后3年11个月目前处于白血病缓解状态。对总共26例LCH后发生ANLL的患者的回顾表明,该疾病预后不良,异基因骨髓移植似乎是首选治疗方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验